ask="1.86"
ask_size="500"
average_daily_volume="243731"
bid="1.60"
bid_size="3200"
book_value="0.34"
change="-0.08"
change_from_200_day_moving_average="-0.15"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-3.49"
change_From_52_week_low="0.50"
change_in_percent="-4.73%"
close="1.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.72"
high_52_weeks="5.10"
last_trade_date="1/24/2017"
last_trade_price="1.61"
last_trade_size="400"
last_trade_time="3:57pm"
low="1.57"
low_52_weeks="1.11"
market_capitalization="15.43M"
moving_average_200_day="1.76"
moving_average_50_day="1.66"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.54%"
percent_change_from_50_day_moving_average="-3.26%"
percent_change_from_52_week_high="-68.43%"
percent_change_from_52_week_low="+45.05%"
previous_close="1.69"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.99"
price_per_sales="31.83"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.97"
stock_exchange="NCM"
symbol="EYEG"
volume="167841"
weeks_range_52="1.11 - 5.10"
